Shichao Lv Selected Research

qishen yiqi

12/2022	QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy.
1/2022	QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology.
11/2021	QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway.
1/2021	QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats.
10/2020	QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy.
3/2016	Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats.
1/2015	Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shichao Lv Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
6	Heart Failure 01/2023 - 01/2019
6	Fibrosis (Cirrhosis) 11/2021 - 01/2015
5	Cardiotoxicity 11/2023 - 01/2019
4	Neoplasms (Cancer) 11/2023 - 09/2019
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2019
2	Aortic Coarctation 11/2021 - 01/2015
2	Inflammation (Inflammations) 10/2020 - 01/2019
2	Myocarditis (Carditis) 07/2018 - 03/2016
1	Melanosis (Freckles) 04/2024
1	Dysbiosis 11/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2023
1	Postherpetic Neuralgia 01/2023
1	Herpes Zoster 01/2023
1	Pain (Aches) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 12/2022
1	Myocardial Infarction 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Ischemia 01/2022
1	Reperfusion Injury 01/2022
1	Hypertrophy 01/2021
1	Atherosclerotic Plaque (Atheroma) 12/2019
1	Rupture 12/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Diabetic Cardiomyopathies 01/2019
1	Ventricular Remodeling 01/2019

Drug/Important Bio-Agent (IBA)

9	CollagenIBA 12/2022 - 01/2015
7	qishen yiqiIBA 12/2022 - 01/2015
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
2	InflammasomesIBA 01/2023 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2021
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 01/2019
2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 01/2022 - 07/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 04/2024
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 04/2024
1	Therapeutic UsesIBA 09/2023
1	ZincIBA 09/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Famciclovir (Famvir)FDA LinkGeneric 01/2023
1	yi-qi-fu-maiIBA 01/2022
1	PowdersIBA 01/2022
1	Oxidants (Oxidizing Agents)IBA 01/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2022
1	Protective AgentsIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	3-methyladenineIBA 11/2021
1	Sirolimus (Rapamycin)FDA Link 11/2021
1	Circular RNAIBA 08/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021
1	AnthracyclinesIBA 07/2021
1	Beclin-1IBA 07/2021
1	Collagen Type III (Type III Collagen)IBA 01/2021
1	Atrial Natriuretic Factor (ANF)IBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Cardiac MyosinsIBA 10/2020
1	LipidsIBA 12/2019
1	trimethylamineIBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2015

Therapy/Procedure

5	Therapeutics 11/2023 - 09/2019
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2023 - 07/2021
1	Patient Readmission 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Ligation 01/2022
1	Duration of Therapy 01/2015